CGRP Therapies Reduced Migraine Days - Top_Thought_Leaders - MDSpire

CGRP Therapies Reduced Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies

  • By

  • Andrea Surnit

  • May 20, 2026

  • 3 min

Share

Top Thought Leaders in Neurology

Brief introduction explaining scope and methodology.

Original Source(s)

CGRP Therapies Reduced Migraine Days

  • by Andrea Surnit

  • May 20, 2026

Related Content

Can a Blood Count Predict Dementia?

Study explores a potential hematological risk marker using real-world data

  • May 20, 2026

  • 2 min
Asthma, Rhinitis Tied to Parkinson's Risk

A nationwide Korean cohort study found modestly higher Parkinson's disease incidence among patients with asthma or allergic rhinitis, with stronger associations observed among patients with greater allergic disease burden.

Tirofiban After Tenecteplase in Stroke

Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.